Post Profile






Scientists discover powerful potential pain reliever

(University of Texas at Austin) Chemists have discovered a powerful pain reliever that acts on a previously unknown pain pathway. The compound is as effective at relieving neuropathic pain in injured mice as a drug widely used for pain relief called gabapentin. If they can demonstrate that it is safe, effective and nonaddictive in humans -- a process that typically takes years -- the discovery could address one of today's biggest public health challenges: the opioid abuse epidemic.
read more

share

Related Posts


Drug Used For Neuropathic Pain Relieves Discomfort From Abdominal Adhesions: Henry Ford Study

Health : Medical News Today

Pregabalin, FDA-approved for neuropathic pain (pain caused by shingles and peripheral neuropathy), effectively reduced abdominal pain and improved sleep in women with adhesions, according to a Henry Ford study. Adhesion pain, a comm...

Vanderbilt scientists discover potential new way to treat anxiety

Academics / General Science : Science Codex

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects, Vanderbilt University scientists will report next week. Endocannabi...

Erectile dysfunction drug relieves nerve damage in diabetic mice

Academics / General Science : ScienceDaily: Science Society

New animal studies found that sildenafil, a drug commonly used to treat erectile dysfunction, may be effective in relieving painful and potentially life-threatening nerve damage in men with long-term diabetes.

Scientists discover and test new class of pain relievers

Academics / General Science : Science Codex

DURHAM, N.C. -- A research team at Duke University has discovered a potential new class of small-molecule drugs that simultaneously block two sought-after targets in the treatment of pain. These proof-of-concept experiments, publish...

Scientists discover, test new class of pain relievers

Academics / General Science : ScienceDaily: Science Society

A potential new class of small-molecule drugs has been discovered that simultaneously inhibit two sought-after targets in the treatment of pain, the ion channels TRPV4 and TRPA1. Their proof-of-concept experiments in mice could lead...

Comments


Copyright © 2016 Regator, LLC